Skip to main content
Fig. 5 | Cancer Imaging

Fig. 5

From: 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer

Fig. 5

Correlations between metastases’ size, patients’ age, serum PSA and SUVmax of metastases. a-c: Correlations according to a Spearman’s correlation, including 95% confidence intervals. A moderate significant association between the SUVmax in liver metastasis and its size (a) was calculated (p ≤ 0.001, ρSpearman = 0.568, 95% CI [0.397, 0.701]). Patient’s age and SUVmax of liver metastases (b) weakly correlate (p ≤ 0.05, ρSpearman = − 0.221, 95% CI [− 0.420; − 0.002]). Serum PSA and SUVmax of liver metastases (c) moderately correlate (p ≤ 0.001, ρSpearman = 0.601, 95% CI [0.419; 0.736]). R2 Coefficient of determination, r Spearman’s rho, SUVmax Maximum standardized uptake value, PSA Prostate-specific antigen

Back to article page